| Published Application/Species/Dilution | Reference |
|---|
- immunocytochemistry; rat; 1:100; fig 3
- western blot; rat; 1:1000; fig 3
| Zhang H, Xiong Z, Wang J, Zhang S, Lei L, Yang L, et al. Glucagon-like peptide-1 protects cardiomyocytes from advanced oxidation protein product-induced apoptosis via the PI3K/Akt/Bad signaling pathway. Mol Med Rep. 2016;13:1593-601 pubmed publisher |
- western blot; human
- immunocytochemistry; human
| Kim D, Park M, Choi J, Lim S, Choi H, Park S. Hyperglycemia-induced GLP-1R downregulation causes RPE cell apoptosis. Int J Biochem Cell Biol. 2015;59:41-51 pubmed publisher |
- immunohistochemistry - paraffin section; rat; 1:100
| Oh T, Shin J, Kang G, Park K, Cho Y. Effect of the combination of metformin and fenofibrate on glucose homeostasis in diabetic Goto-Kakizaki rats. Exp Mol Med. 2013;45:e30 pubmed publisher |
- immunohistochemistry - frozen section; pig; 1:25
- western blot; pig
| Moberly S, Mather K, Berwick Z, Owen M, Goodwill A, Casalini E, et al. Impaired cardiometabolic responses to glucagon-like peptide 1 in obesity and type 2 diabetes mellitus. Basic Res Cardiol. 2013;108:365 pubmed publisher |
| Lietzau G, Nystrom T, Ostenson C, Darsalia V, Patrone C. Type 2 diabetes-induced neuronal pathology in the piriform cortex of the rat is reversed by the GLP-1 receptor agonist exendin-4. Oncotarget. 2016;7:5865-76 pubmed publisher |
| He J, Wang C, Sun Y, Lu B, Cui J, Dong N, et al. Exendin-4 protects bone marrow-derived mesenchymal stem cells against oxygen/glucose and serum deprivation-induced apoptosis through the activation of the cAMP/PKA signaling pathway and the attenuation of ER stress. Int J Mol Med. 2016;37:889-900 pubmed publisher |
| Zhao X, Liu G, Shen H, Gao B, Li X, Fu J, et al. Liraglutide inhibits autophagy and apoptosis induced by high glucose through GLP-1R in renal tubular epithelial cells. Int J Mol Med. 2015;35:684-92 pubmed publisher |
| Yao D, Yang L, Wang Y, Liu C, Wei Y, Jia X, et al. Geniposide promotes beta-cell regeneration and survival through regulating β-catenin/TCF7L2 pathway. Cell Death Dis. 2015;6:e1746 pubmed publisher |
| Nomiyama T, Kawanami T, Irie S, Hamaguchi Y, Terawaki Y, Murase K, et al. Exendin-4, a GLP-1 receptor agonist, attenuates prostate cancer growth. Diabetes. 2014;63:3891-905 pubmed publisher |
| Gong N, Fan H, Ma A, Xiao Q, Wang Y. Geniposide and its iridoid analogs exhibit antinociception by acting at the spinal GLP-1 receptors. Neuropharmacology. 2014;84:31-45 pubmed publisher |
| Gong N, Xiao Q, Zhu B, Zhang C, Wang Y, Fan H, et al. Activation of spinal glucagon-like peptide-1 receptors specifically suppresses pain hypersensitivity. J Neurosci. 2014;34:5322-34 pubmed publisher |
| Zhu B, Gong N, Fan H, Peng C, Ding X, Jiang Y, et al. Lamiophlomis rotata, an orally available Tibetan herbal painkiller, specifically reduces pain hypersensitivity states through the activation of spinal glucagon-like peptide-1 receptors. Anesthesiology. 2014;121:835-51 pubmed publisher |
| Moberly S, Berwick Z, Kohr M, Svendsen M, Mather K, Tune J. Intracoronary glucagon-like peptide 1 preferentially augments glucose uptake in ischemic myocardium independent of changes in coronary flow. Exp Biol Med (Maywood). 2012;237:334-42 pubmed publisher |
| Yang H, Li H, Wang Z, Shi Y, Jiang G, Zeng F. Exendin-4 ameliorates renal ischemia-reperfusion injury in the rat. J Surg Res. 2013;185:825-32 pubmed publisher |
| Sonoda N, Imamura T, Yoshizaki T, Babendure J, Lu J, Olefsky J. Beta-Arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic beta cells. Proc Natl Acad Sci U S A. 2008;105:6614-9 pubmed publisher |
| Chaykovska L, Alter M, von Websky K, Hohmann M, Tsuprykov O, Reichetzeder C, et al. Effects of telmisartan and linagliptin when used in combination on blood pressure and oxidative stress in rats with 2-kidney-1-clip hypertension. J Hypertens. 2013;31:2290-8; discussion 2299 pubmed publisher |
| Panjwani N, Mulvihill E, Longuet C, Yusta B, Campbell J, Brown T, et al. GLP-1 receptor activation indirectly reduces hepatic lipid accumulation but does not attenuate development of atherosclerosis in diabetic male ApoE(-/-) mice. Endocrinology. 2013;154:127-39 pubmed publisher |
| Gier B, Butler P, Lai C, Kirakossian D, Denicola M, Yeh M. Glucagon like peptide-1 receptor expression in the human thyroid gland. J Clin Endocrinol Metab. 2012;97:121-31 pubmed publisher |
| Romaní-Pérez M, Outeiriño-Iglesias V, Gil-Lozano M, Gonzalez-Matias L, Mallo F, Vigo E. Pulmonary GLP-1 receptor increases at birth and exogenous GLP-1 receptor agonists augmented surfactant-protein levels in litters from normal and nitrofen-treated pregnant rats. Endocrinology. 2013;154:1144-55 pubmed publisher |
| Gupta N, Mells J, Dunham R, Grakoui A, Handy J, Saxena N, et al. Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway. Hepatology. 2010;51:1584-92 pubmed publisher |
